Diurnal Cortisol Rhythm Is Associated With Adverse Cardiac Events and Mortality in Coronary Artery Bypass Patients by Ronaldson, A et al.
Diurnal Cortisol Rhythm Is Associated With Adverse
Cardiac Events and Mortality in Coronary Artery
Bypass Patients
Amy Ronaldson, Tara Kidd, Lydia Poole, Elizabeth Leigh, Marjan Jahangiri,
and Andrew Steptoe
Department of Epidemiology and Public Health (A.R., T.K., L.P., E.L., A.S.), University College London,
London WC1E 6BT, United Kingdom; and Department of Cardiac Surgery (M.J.), St. George’s Hospital,
University of London, London SW17 0QT, United Kingdom
Purpose: There is growing evidence that the hypothalamic-pituitary-adrenal axis plays a role in the
progression of cardiovascular disease. We examined the relationship between diurnal cortisol
rhythmandadverseevents inpatientsundergoingcoronaryarterybypassgraft (CABG) surgery.We
hypothesized that a flatter presurgical diurnal cortisol slopewould be associatedwith higher rates
of adverse cardiac events and death in the years following the CABG procedure.
Methods: Repeated measures of saliva were taken over the day from 250 CABG patients 1 month
before surgery to assess diurnal cortisol slope andoverall output (areaunder the curve). Long-term
clinical outcomes were occurrence of a major adverse cardiac event (MACE) and death, and were
collected up to 2.68 (SD 0.40) years after surgery. Cox proportional hazard models were used to
determine relationships between presurgical cortisol and clinical outcomes. EuroSCORE, chronic
illness burden, and whether or not the patient had undergone cardiopulmonary bypass were
included as covariates in the models.
Results: Diurnal cortisol slope predicted the occurrence of MACE or death after surgery (hazard
ratio  0.73; 95% confidence interval  0.56–0.96; P  .023). Patients with a steeper slope were
at reduced risk of adverse outcomes. This association was driven by changes in both waking and
evening cortisol levels.
Conclusion: These results provide evidence for a link betweendiurnal cortisol rhythmand recovery
after CABG.Measuring diurnal cortisol slope before surgerymay help to identify those patients at
riskof adverseoutcomes in the years after theprocedure. (J Clin EndocrinolMetab100: 3676–3682,
2015)
There is growing evidence that the hypothalamic-pitu-itary-adrenal (HPA) axis plays a role in the progres-
sion of cardiovascular disease (CVD). The HPA axis is a
major component of the neuroendocrine system that con-
trols the stress response and a number of important bodily
functions. Cortisol is the end product of theHPA axis and
influences a number of factors relevant to the etiology of
CVD. There is growing evidence that elevated cortisol lev-
els are associated with adiposity, low-density lipoprotein
cholesterol levels, endothelial dysfunction, increases in
blood pressure, and hemostasis (1). Cortisol also plays a
regulatory role in the complex relationship between in-
flammation and vascular disease (2). Heightened cortisol
levels have been associated with subclinical atherosclero-
sis of the carotid arteries (3) and coronary artery calcifi-
cation (4). Furthermore, rates of CVD are high in people
withCushing’s syndrome—adisease defined by hypercor-
tisolism (5). Elevated 24-hour urinary cortisol has been
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found to predict cardiovascular death in older people both
with and without CVD (6). However, the role of cortisol
in patients with advanced CVD is less clear. Higher serum
cortisol levels have been found to predict both mortality
risk and risk of future cardiac events in chronic heart fail-
ure (7) and ischemic stroke (8). However, results from
studies of cortisol in acute coronary syndrome have been
less consistent (9, 10).
One difficulty in interpreting this evidence is that cor-
tisol is typically measured with a single serum sample.
Cortisol showsmarked diurnal patterning, and levels vary
substantially across the day. Cortisol is at high levels on
waking, followed by a rise that reaches a peak approxi-
mately 30 minutes after waking. This is referred to as the
cortisol awakening response. There is then a subsequent
decline across the day, with cortisol reaching its lowest
point at around midnight. It is possible that differences in
the point during the diurnal cycle at which single serum
samples are obtained account for inconsistencies in asso-
ciations with CVD. Sampling cortisol several times across
the day allows for measurement of the diurnal cortisol
profile and a more in depth investigation of the associa-
tions between cortisol and clinical endpoints. Dysregula-
tion of the HPA axis can result in a reduction in the am-
plitude of the diurnal pattern or a flatter slope across the
day (11). A flatter cortisol slope across the day has been
associated with higher levels of coronary artery calcifica-
tion (11) and increased cardiovascular mortality in non-
clinical populations (12).
There is a paucity of studies examining the effects of
variations in diurnal cortisol rhythms on future cardiac
events andmortality inpatientswith establishedCVD.We
therefore sought to examine the relationship between pre-
surgical diurnal cortisol and clinical outcomes in patients
undergoing coronary artery bypass graft (CABG) surgery.
Wehypothesized that a flatterdiurnal cortisol slopebefore
surgery would be associated with higher rates of future
cardiac events and mortality in the years after CABG.
Subjects and Methods
Participants
The data we used in this analysis were collected as part of the
Adjustment and Recovery after Cardiac Surgery (ARCS) study
involving patients undergoing elective CABG surgery or CABG
plus valve replacement to participate. CABG surgery in a single
center (13) included both on-pump and off-pump procedures.
All procedureswere carriedoutwithwritten informed consent of
the participants. Ethical approval was obtained from the Na-
tional Research Ethics Service.
Participants were 262 prospective CABG patients who were
recruited from a presurgical assessment clinic at St. George’s
Hospital,London.Eligibleparticipantshad tobeat least18years
of age and had to be able to complete questionnaires in English.
Long-term recovery outcomes were collected from electronic
and paper patient records on average 2.68 (SD  0.40) years
after surgery.We carried out analyses on 250 patients with com-
plete data on clinical outcomes and cortisol slope. Therewere no
significant associations between the use of steroid medications
and cortisol output, outcome variables, or covariates (all P 
.05). Therefore, patients taking steroidmedications (n 8)were
included in the analyses.
There were no significant differences between patients in-
cluded in and excluded from the analyses in terms of age, sex, the
occurrence of major adverse cardiac events (MACEs), chronic
disease burden, or whether or not the person had on-pump sur-
gery. However, EuroSCOREwas higher in the 12 patients with-
out cortisol follow-up data (F (2, 345)  5.233; P  .006) in-
dicating poorer prognosis on average.
Measures
Diurnal salivary cortisol
At the presurgical assessment clinic, participants received a
saliva collection kit and were given instructions for collection at
home. The kit included seven prelabeled “salivette” collection
tubes (Sarstedt) and a cortisol diary. The cortisol diary contained
instructions on how and when to give samples. These diaries
were also used to record information on factors likely to intro-
duce variation in cortisol samples such as mood, exercise, and
daily stressors. Participants provided seven saliva samples over
the course of a weekday: on waking, 30 minutes after waking
(30), 10 AM, noon, 4 PM, 8 PM, and bedtime. Participants stored
their samples in the refrigerator before returning them to the
clinic. The samples were obtained on average 30.6 days (SD 
36.9) before surgery. Cortisol levels were assessed from saliva
using a time-resolved immunoassay with fluorescence detection
at the University of Dresden, Germany.
Wecomputed total cortisol output over thedayby calculating
the cortisol area under the curve (AUC) with respect to ground
(14). The cortisol slopewas calculated in nanomoles per liter per
hour (nmol/L/h) by regressing cortisol on sample collection time,
with 30 excluded; higher values indicate a steeper decrease in
cortisol over the day. Waking and evening (the average of 8 PM
and bedtime) values were also calculated.
Long-term clinical outcome
Long-termclinical outcomeswereoccurrenceof aMACEand
death (all-cause mortality) and were collected up to 2.68 years
after surgery. Postoperative MACE included admissions for
myocardial infarction, unstable angina, stroke, and/or heart fail-
ure.Occurrence ofMACEwas treated as a binary variablewhere
either noMACE occurred or at least oneMACE occurred.Mor-
tality data were gathered by reviewing in-hospital electronic and
paper patient records.
Covariates: clinical, sociodemographic, and
psychosocial factors
Cardiovascular history and clinical factors during admission
andmanagementwere obtained from clinical notes. Clinical risk
was assessed using the European System for Cardiac Operative
Risk Evaluation (EuroSCORE) (15). EuroSCORE is a combined
measure of procedural mortality risk based on 17 factors com-
prising patient-related factors (eg, age, sex), cardiac-related fac-
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tors (eg, unstable angina, recentmyocardial infarction), and sur-
gery-related factors (eg, surgery on thoracic aorta). Items were
scored in accordancewith the “logistic EuroSCORE”method to
generate a percentage mortality risk estimate; further details of
the scoring method can be found on the EuroSCORE web site
(www.euroscore.org/logisticEuroSCORE.htm). In addition, we
recordedwhether a patient underwent cardiopulmonary bypass.
Participants were asked to report any long-standing illnesses
apart from heart disease before surgery (eg, cancer, thyroid dis-
order, diabetes); responses were summed to compute a chronic
illness burden variable.
Statistical analyses
A composite outcome was created combining MACE and
mortality. Cox proportional hazards models were used to de-
termine relationships between cortisol before surgery and clin-
ical outcome;when a patient experiencedmore than oneMACE,
the earliest time interval from baseline was analyzed. Separate
models were fitted for the cortisol slope over the day, cortisol
AUC, and waking and evening values.
Because of the low number of clinical events (n  18), only
three covariates were included in the Cox regression models to
avoid overfitting. Therefore, we included those covariates
deemed most clinically relevant: EuroSCORE, whether the pa-
tient underwent cardiopulmonary bypass, and chronic illness
burden. Because depression is known to be an important pre-
dictor of mortality in patients with CVD (16) and is also known
to affect HPA axis activity (17), we examined associations be-
tween presurgical depression scores and presurgical cortisol pa-
rameters. Therewere no significant associations betweendepres-
sion and cortisol (all P  .05). Therefore, we did not include
pre-surgical depressionasa covariate in theanalyses.Ageandsex
were not adjusted for separately in the Cox regression models
because both age and sex are included in the EuroSCORE.
Associations between presurgical cortisol and covariates
were examined using Pearson’s correlations for continuous data
and independent t tests for categorical variables.The significance
level was set to P  .05 for all analyses, with precise P values
reported for all test results. All statistical analyses were per-
formed using SPSS version 20.0 (SPSS Inc).
Results
Table 1 summarizes the characteristics of the patients. The
sample had an age range of 44–90 years, was predomi-
nantly male (86.4%), and was overweight (body mass in-
dex [BMI] 25 kg/m2, 81.6%). Just under one-fourth of
the patients were diabetic (24%). The majority had on-
pump cardiopulmonary bypass surgery (79.2%). In the
years after surgery (mean  2.68 y; SD  0.40), nine pa-
tients (3.6%) experienced a MACE and 10 patients
(4.0%) died, with one individual experiencing both out-
comes. Cortisol slope, cortisol AUC, and waking cortisol
levels were not significantly associated with EuroSCORE,
cardiopulmonary bypass, or chronic illness burden. Eve-
ning cortisol levels were associatedwith EuroSCORE (r
0.14; P .030) but not with cardiopulmonary bypass or
chronic illness burden. Occurrence of death or MACE af-
ter surgery was associated with EuroSCORE (r  0.24;
P .001) and chronic illness burden (r 0.19; P .003).
Presurgical cortisol and clinical outcomes
Diurnal cortisol slopepredicted theoccurrenceof death
orMACE after CABG surgery (hazard ratio 0.73; 95%
confidence interval [CI] 0.56–0.96; P .023). Patients
with a steeper cortisol decline over the daywere at reduced
risk of experiencing adverse clinical outcomes (Table 2).
More specifically, these results indicate that for every 1
nmol/L/h increase in cortisol slope, the risk of death or
MACE fell by 27%.Chronic illness burden (P .035) and
EuroSCORE (P  .002) also predicted death or MACE
after surgery. These analyses were repeated after exclud-
ing immediate events (three events) that occurred in the
5-day postoperative period. A steeper presurgical cortisol
slope remained predictive of reduced risk of adverse clin-
ical outcomes (HR  0.70; 95% CI  0.52–0.94; P 
.017). For every 1 nmol/L/h increase in cortisol slope, the
risk of death or MACE after the 5-day postoperative pe-
riod fell by 30%. These survival analyses were carried out
treating cortisol slope as a continuous variable, but for
descriptive purposes participantswere split into two equal
groups based on cortisol slope using a median split. Cor-
tisol changes over the day  1.68 nmol/L/h were consid-
ered indicative of “flatter” slopes. Kaplan-Meier survival
Table 1. Demographic, Cortisol, and Clinical
Characteristics of the Sample at Baseline and Follow-Up
(n  256)
Characteristic
Age, y 68.10  8.87
Female 34 (13.6)
BMI, kg/m2 28.84  4.37
Smoker 20 (8.0)
Comorbidities
Diabetes 60 (24.0)
Chronic illness burden
No other chronic illness 156 (62.4)
1 other chronic illness 74 (29.6)
2 other chronic illnesses 20 (8.0)
Presurgical measures of cortisol
Slope, nmol/L/h 1.67  1.31
AUC, nmol/L 8874.55  2770.55
Waking cortisol, nmol/L 19.45  8.71
Time of waking, h:min 06:56  01:12
Average evening cortisol, nmol/L 4.37  3.81
Clinical factors
Logistic EuroSCORE, % 4.49  3.06
No. of grafts 2.97  1.13
On-pump 198 (79.2)
Long-term recovery
MACE 9 (3.6)
Deceased 10 (4.0)
Data are expressed as mean  SD or number (percentage), unless
stated otherwise.
3678 Ronaldson et al Cortisol Slope and Adverse Events After Surgery J Clin Endocrinol Metab, October 2015, 100(10):3676–3682
The Endocrine Society. Downloaded from press.endocrine.org by [${individualUser.displayName}] on 07 June 2016. at 08:12 For personal use only. No other uses without permission. . All rights reserved.
plots of the two groups are shown in Figure 1. This plot
reveals that divergence in survival/occurrence ofMACEas
a function of cortisol slope emerges very soon after CABG
surgery.
A flatter cortisol slope across the day can be due to low
cortisol output on waking and/or higher evening cortisol
values.We therefore examined associations between both
waking and evening cortisol and clinical outcome. Wak-
ing cortisolwas inversely associatedwith clinical outcome
(HR 0.93; 95%CI 0.88–0.98; P .011), suggesting
that higher cortisol output on waking is linked to event-
free survival. Evening cortisol levelswere also significantly
associated with clinical outcome (HR  1.09; 95% CI 
1.014–1.170; P  .019), indicating that higher evening
cortisol is linked to MACE or death in the years after
surgery.
We also examined the association between cortisol
AUC and adverse clinical outcomes. Presurgical AUC did
not predict survival or the occurrence of MACE in the
years after bypass surgery (P .271). Excluding death or
MACEthatoccurred in the5-daypostoperativeperioddid
not change these results.
Discussion
The results of the study suggest that a flatter diurnal cor-
tisol slope before surgery predicts the occurrence of
MACE or mortality in CABG patients. Cortisol was sam-
pled 1 month before surgery, so it does not reflect acute
anticipatory stress responses before surgery. Our findings
suggest that a flatter cortisol slope is related to poorer
long-term outcomes in a patient sample with advanced
CVDafter bypass surgery and that this association is being
driven by alterations in both waking and evening cortisol.
These associations were independent of EuroSCORE,
whether or not the patient underwent cardiopulmonary
bypass, and chronic illness burden. There was no associ-
ation between presurgical cortisol AUC and adverse clin-
ical outcomes in the years following surgery.
To our knowledge, this is the first study to examine the
association between diurnal cortisol and the occurrence of
MACE or mortality in the years after CABG surgery. Our
findings are in line with research that has reported asso-
ciations between flatter diurnal slopes and adverse clinical
events in other serious illnesses. For example, a flatter
cortisol slope has been found to predict worse prognosis
andmortality inmetastatic breast cancer, lung cancer, and
epithelial ovarian cancer (18–20). Flatter diurnal rhythms
have also been associated with psychological stress and
adversity, including depression (21), early childhood ad-
versity (22), chronic stress (23), aging, and visceral obesity
(1). Many of these factors are associated with coronary
heart disease incidence (24) and also contribute to recur-
Table 2. Results of Cox Regression Analysis, Showing Predictive Effects of Cortisol Slope and Covariates on the
Occurrence of MACE and/or Death in the Years After CABG Surgery
Variable Coefficient (B) SE Wald 2 P
Hazard
Ratio 95% CI
Cortisol slope 0.31 0.14 5.16 .023 0.73 0.56–0.96
Chronic illness burden 0.67 0.32 4.46 .035 1.96 1.05–3.65
EuroSCORE 0.18 0.06 9.27 .002 1.20 1.07–1.35
Bypassa 0.28 0.67 0.18 0.67 0.75 0.20–2.79
This model includes MACE/mortality cases that occurred within the 5-day postoperative period. Bold face indicates P values with statistical
significance (P  .05).
a Whether the patient underwent cardiopulmonary bypass.
Figure 1. Kaplan-Meier survival curves for patients split into two
equal groups at the median diurnal cortisol slope. This median split
was performed only for illustrative purposes.
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rent events and mortality in patients with advanced dis-
ease (25). Patients with heart disease have been found to
have a flatter cortisol rhythm comparedwith healthy con-
trols (26). The association between cortisol rhythm and
mortality and adverse events in the current sample indi-
cates that HPA axis dysregulation may increase with dis-
ease progression.
Our results indicate that both waking and evening cor-
tisol levels predicted adverseoutcomes forCABGpatients,
so the adverse effects of flatter profiles are not the result
only of reducedwaking concentration or elevated evening
values. Kumari et al (12) found that an association be-
tween flatter cortisol slope and CVD mortality in a non-
clinical samplewas driven primarily by changes in evening
levels of cortisol only.One reason for this discrepancymay
be that HPA axis dysregulation has progressed further in
individualswith advancedCVD.Fatigue andvital exhaus-
tion are associated with cortisol output, as well as being
risk factors for the occurrence of adverse cardiac events
over time (27, 28). Associations between lower levels of
waking cortisol and fatigue have been reported in older
adults and coronary artery disease patients (29, 30). It is
possible that fatigue or exhaustion may be a factor influ-
encing the association between lower waking cortisol and
adverse outcomes in the current study.
It is likely that one of the factors contributing to the link
between cortisol rhythm and MACE/mortality is inflam-
mation. The role of inflammation in atherosclerosis iswell
established, with higher levels of proinflammatory cyto-
kines being associated with enhanced plaque instability
and acute thrombotic complications (31, 32). Elevations
of inflammatory markers are also independent predictors
of future cardiovascular events (33). The HPA axis is
one of the major mechanisms by which inflammation is
regulated. Cortisol exerts an immunomodulatory effect
inhibiting the expression of inflammatory cytokines such
as IL-6, IL-1, and TNF- (34). Dysregulation of the HPA
axis may result in the impairment of inhibition, leading to
sustained high levels of inflammation (35). Nijm et al (26)
found that individuals with coronary artery disease had a
flattened cortisol slope compared with healthy controls
and that levels of evening cortisolwere strongly correlated
with serum levels of IL-6 andC-reactive protein. Similarly,
a flattened cortisol slope has been associated with higher
circulating levels of plasma IL-6 in epithelial ovarian can-
cer (20) and metastatic colorectal cancer (36).
CABG surgery leads to substantial increases in cortisol
concentration that decline over the postoperative period
and is coupled with alterations in sensitivity to ACTH
(37). Mechanistically, dysregulation of the HPA axis is
likely caused in part by diminished sensitivity of the main
corticosteroid receptors—the glucocorticoid receptor
(GR) and the mineralocorticoid receptor (MR). Cortisol
exerts its effects by binding to the GR and MR, which
subsequently down-regulates proinflammatory gene tran-
scription (38). With reduced corticosteroid receptor sen-
sitivity, cortisol is no longer able to exert its regulatory
effects successfully, leading to a breakdown in the HPA
axis negative feedback loopandan increase in the intensity
of the inflammatory response (39). GRs are expressed in
cardiovascular tissue and are responsible for maintaining
vascular tone and modifying vascular inflammatory re-
sponses (40). GRs have also been shown to exert anti-
inflammatoryactions in cardiacmuscle cells (41).MRsare
expressed in vascular smooth muscle cells and play a role
in regulating vascular function (42). Moreover, spirono-
lactone, a MR antagonist, is a powerful antifibrotic used
in the treatment of heart failure and atrial fibrillation (43).
Therefore diminished sensitivity of the corticosteroid recep-
tors may have direct effects on the heart. Diminished GR
sensitivity has been associated with a flatter diurnal cortisol
slope (44). It is possible that the association between diurnal
cortisol slope and MACE or mortality observed in the cur-
rent study reflects reduced sensitivity of the corticosteroid
receptors.Future researchshouldassessbothdiurnal cortisol
rhythm and GR and MR function in CVD patients.
In our study, we found no association between overall
cortisol output (AUC) and MACE or mortality after
CABG surgery. A study of lung cancer survival also found
that cortisol AUChad no predictive value in terms ofmor-
tality (18). This adds support to the notion thatmeasuring
cortisol slope across the day is likely to be a more useful
prognostic tool than total cortisol output and that the
diurnal rhythmmay be related to specific circadian mech-
anisms of inflammation (45).
A strength of this study is that cortisol was measured
repeatedly across a day several weeks before surgery. The
patternofoutputmay therefore representhabitualprofiles
rather than being affected by acute anticipation of hospi-
talization. The study had a prospective design, and attri-
tion was low, with ascertainment of clinical outcomes in
more than 95% of participants. However, the sample size
was relatively small, with MACE and death occurring in
only 18 participants. TheARCS studywas not specifically
designed to investigate cortisol and cardiac outcomes, and
this limited statistical power and reduced the number of
covariates that could be included in the analyses. Larger
studies of patients with advanced cardiac disease are
needed to establish the robustness of the findings. Our
sample was largely composed of white men of European
origin, so the results may not be readily generalizable to
other groups.Wewere unable to access information about
specific causes of death for all patients who died. Cortisol
was measured over a single day, meaning that the diurnal
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rhythmmay have been affected by situational rather than
chronic factors. Nighttime cortisol was not measured, so
it was not possible to assess total 24-hour cortisol expo-
sure. Furthermore, these data do not prove a causal con-
nection between diurnal cortisol slope andMACEormor-
tality in these patients; although we included important
clinical covariates, there might be unmeasured factors in-
fluencing diurnal cortisol rhythms that also increased risk
of adverse outcomes.
In conclusion, our results indicate that a flatter diurnal
cortisol slope before surgery is associated with poorer
long-term outcomes in patients undergoing coronary re-
vascularization. Diurnal cortisol profiles can be obtained
without difficulty because the measures are noninvasive
and samples are stable for several days.Measuring diurnal
cortisol rhythm may help to identify patients at risk of
adverse events or death, allowing additional support and
care to be provided.
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